Viewing Study NCT01765803


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2026-01-04 @ 8:38 PM
Study NCT ID: NCT01765803
Status: TERMINATED
Last Update Posted: 2016-04-14
First Post: 2013-01-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells
Sponsor: New Mexico Cancer Research Alliance
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-06
Start Date Type: None
Primary Completion Date: 2013-11
Primary Completion Date Type: ACTUAL
Completion Date: 2013-12
Completion Date Type: ACTUAL
First Submit Date: 2013-01-08
First Submit QC Date: None
Study First Post Date: 2013-01-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-06-19
Results First Submit QC Date: None
Results First Post Date: 2015-07-20
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-03-15
Last Update Post Date: 2016-04-14
Last Update Post Date Type: ESTIMATED